This contract involves the supply of antiretroviral medications to a storage warehouse. The specific items required are as follows: Part 1: Maraviroc | 150mg | tablet | 60 units; Part 2: Dolutegravir/Lamivudine | 50/300mg | tablet | 30 units; Part 3: Dolutegravir/Lamivudine | 50/300mg | tablet | 30
Contract awarded. Originally published 5 months ago.
This contract involves the supply of antiretroviral medications to a designated storage facility. The procurement is divided into five parts: Part 1: Maraviroc | 150mg | tablet | 60 units; Part 2: Dolutegravir/Lamivudine | 50/300mg | tablet | 30 units; Part 3: Dolutegravir/Lamivudine | 50/300mg | ta
The contract involves the supply of antiretroviral medications to a designated storage facility. The specific medications required are as follows: Part 1: Maraviroc | 300mg | tablet | 60 units; Part 2: Rilpivirine | 900mg | ampoule | 1 unit; Part 3: Cabotegravir | 600mg | ampoule | 1 unit; Part 4: D
This contract involves the procurement of medical diagnostic products for molecular diagnostics, specifically diagnostic tests necessary for monitoring antiretroviral therapy in patients infected with HIV and those suffering from AIDS. The products will be delivered directly to laboratories conducti
This contract involves the supply of antiretroviral medications to a designated storage facility. The procurement is divided into three parts: Part 1 includes Cabotegravir (30mg, 30 tablets), Part 2 includes Lamivudine (150mg, 60 tablets), and Part 3 includes Lamivudine (300mg, 30 tablets). Supplier
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
